Exparel Versus Bupivacaine in Post-operative Pain Control

Phase 4 Completed 82 enrolled Case Western Reserve University

RandomizedParallel-groupSingle-blindTreatment

Summary

This is a prospective, randomized study to evaluate anaesthetic parameters, postoperative analgesia and oral analgesic consumption comparing exparel (liposomal bupivacaine) vs. standard bupivacaine

Timeline

Start: 2024-08-21
Primary completion: 2025-07-01
Completion: 2025-07-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Bupivacaine	Other / unclassified	0.5 %	Other
Subject	Bupivacaine	Other / unclassified	1.3 %	Other
Subject	Bupivacaine	Other / unclassified	3 ml	Other

Indications

No indication recorded.